Posted By Connections Editor,
Wednesday, July 1, 2015
Updated: Monday, June 29, 2015
| Comments (0)
Shahin Rafii, who is part of a consortium of scientists and transplant clinicians from the Ansary Stem Cell Institute at Weill Cornell Medical College and the Center for Cell Engineering at Memorial Sloan Kettering Cancer Center that has been awarded a $15.7 million, four-year research grant from the New York State Stem Cell Science Program to translate their innovative approach to expand and manipulate hematopoietic stem cells to cure acquired and inherited blood disorders.
Mickie Bhatia: Single Transcription Factor Conversion of Human Blood Fate to NPCs with CNS and PNS Developmental Capacity. Cell reports, Published Online: May 21, 2015.
Ihor R. Lemischka: Modeling Familial Cancer with Induced Pluripotent Stem Cells. Cell, 2015; 161, 240–254, and Tex10 Coordinates Epigenetic Control of Super-Enhancer Activity in Pluripotency and Reprogramming. Cell Stem Cell, 2015;16:1–16.
Iannis Aifantis: TET1 is a tumor suppressor of hematopoietic malignancy. Nat Immunol. 2015;16:653-662.
George Q. Daley and Leonard I. Zon: Adenosine signaling promotes hematopoietic stem and progenitor cell emergence. JEM, 2015; 212: 649.
Margaret A. Goodell: Long Non-Coding RNAs Control Hematopoietic Stem Cell Function. Cell Stem Cell. 2015;16:426-38.
Guy Sauvageau: Haploinsufficiency screen highlights two distinct groups of ribosomal protein genes essential for embryonic stem cell fate. Proc Natl Acad Sci U S A., 2015;112:2127-32.
David G. Kent, Anthony R. Green and Berthold Göttgens: Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations. Cell Stem Cell, Available online 21 May 2015.
This post has not been tagged.